ORAGENICS INC (OGEN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 600K 1.2M 1.8M Q4 '10: 1.3M Q1 '11: 1.3M Q2 '11: 1.4M Q1 '12: 1.5M Q2 '12: 1.4M Q3 '12: 1.3M Q4 '12: 1.3M Q1 '13: 1.1M Q2 '13: 1M Q3 '13: 1M Q4 '13: 1M Q1 '14: 1.1M Q2 '14: 1.2M Q3 '14: 1.2M Q4 '14: 939.9K Q1 '15: 1.1M Q1 '16: 1.1M Q2 '16: 832.3K Q3 '16: 502.5K Q4 '16: 262.3K Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q4 '22: 131.5K Q1 '23: 133.5K Q2 '23: 116.2K Q3 '23: 37.7K Q4 '23: 37.7K Q2 '11 Q1 '13 Q2 '14 Q2 '16 Q3 '17 Q4 '18 Q4 '23

Gross Profit TTM

0 300K 600K 900K Q4 '12: 453.3K Q1 '13: 383.4K Q2 '13: 320.3K Q3 '13: 360.1K Q4 '13: 688.9K Q1 '14: 711.3K Q2 '14: 808.5K Q3 '14: 795.8K Q4 '14: 570.3K Q1 '15: 631.2K Q4 '16: 0 Q4 '12 Q2 '13 Q4 '13 Q2 '14 Q4 '14 Q4 '16

Operating Income TTM

-30M -20M -10M 0 10M 20M 30M Q4 '10: -7.9M Q1 '11: -7.7M Q2 '11: -8M Q3 '11: -7.8M Q4 '11: -7.3M Q1 '12: -7.3M Q2 '12: -11.9M Q3 '12: -12.3M Q4 '12: -12.4M Q1 '13: -12.7M Q2 '13: -7.9M Q3 '13: -15.1M Q4 '13: -16.2M Q1 '14: -16.1M Q2 '14: -16M Q3 '14: -7.7M Q4 '14: -5.8M Q1 '15: -5.5M Q1 '16: -12.5M Q2 '16: -7.9M Q3 '16: -8M Q4 '16: -8.5M Q1 '17: -8.5M Q2 '17: -8.1M Q3 '17: -8M Q4 '17: -6.7M Q1 '18: -6.9M Q2 '18: -7.7M Q1 '19: -11.3M Q2 '19: -13.9M Q3 '19: -15M Q4 '19: -15.9M Q1 '20: -17.7M Q2 '20: -25.2M Q3 '20: -25.8M Q4 '20: -26.6M Q1 '21: -26.6M Q2 '21: -18.1M Q3 '21: -18M Q4 '21: -15.8M Q1 '22: -15.1M Q2 '22: -14.9M Q3 '22: -14.4M Q4 '22: -14.4M Q1 '23: -12.7M Q2 '23: -12.2M Q3 '23: -10.4M Q4 '23: -20.9M Q1 '24: -20.5M Q2 '24: -19.7M Q3 '24: -20M Q4 '24: -10.6M Q1 '25: -10.1M Q2 '25: -9.5M Q3 '25: -10.2M Q4 '25: -9.4M Q1 '26: -9.6M Q2 '26: -10.5M Q1 '11 Q1 '13 Q1 '15 Q4 '17 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income TTM

-27M -18M -9M 0 9M 18M 27M Q4 '10: -7.8M Q1 '11: -7.6M Q2 '11: -8M Q1 '12: -7.7M Q2 '12: -12.3M Q3 '12: -13M Q4 '12: -13.1M Q1 '13: -13.1M Q2 '13: -8.2M Q3 '13: -15M Q4 '13: -16.1M Q1 '14: -16.1M Q2 '14: -15.9M Q3 '14: -7.6M Q4 '14: -5.8M Q1 '15: -5.4M Q1 '16: -12.5M Q2 '16: -6.5M Q3 '16: -6.6M Q4 '16: -7M Q1 '17: -6.9M Q2 '17: -7.8M Q3 '17: -7.9M Q4 '17: -6.7M Q1 '18: -6.9M Q2 '18: -7.9M Q1 '19: -11.1M Q2 '19: -13.6M Q3 '19: -14.7M Q4 '19: -15.6M Q1 '20: -17.4M Q2 '20: -25M Q3 '20: -25.6M Q4 '20: -26.4M Q1 '21: -26.5M Q2 '21: -17.9M Q3 '21: -17.8M Q4 '21: -15.7M Q1 '22: -15.1M Q2 '22: -14.9M Q3 '22: -14.3M Q4 '22: -14.3M Q1 '23: -12.5M Q2 '23: -12M Q3 '23: -10.1M Q4 '23: -20.7M Q1 '24: -20.3M Q2 '24: -19.5M Q3 '24: -20M Q4 '24: -10.6M Q1 '25: -10.3M Q2 '25: -10.3M Q3 '25: -10.9M Q4 '25: -9.8M Q1 '26: -9.8M Q2 '26: -10.1M Q4 '12 Q3 '14 Q1 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-18M -12M -6M 0 6M 12M 18M Q2 '11: -5.8M Q3 '11: -5.9M Q4 '11: -5.5M Q1 '12: -5.5M Q2 '12: -5.2M Q3 '12: -4.9M Q4 '12: -5.2M Q1 '13: -5.6M Q2 '13: -6.5M Q3 '13: -7.3M Q4 '13: -6.8M Q1 '14: -6.8M Q2 '14: -6.5M Q3 '14: -5.6M Q4 '14: -5.6M Q1 '15: -5.3M Q2 '15: -4.5M Q3 '15: -4.8M Q4 '15: -5.2M Q1 '16: -5.6M Q2 '16: -6.5M Q3 '16: -6.8M Q4 '16: -7.1M Q1 '17: -7.4M Q2 '17: -7.2M Q3 '17: -7M Q4 '17: -6.4M Q1 '18: -5.8M Q2 '18: -6.3M Q3 '18: -7.5M Q4 '18: -9.1M Q1 '19: -9.9M Q2 '19: -11.1M Q3 '19: -12.1M Q4 '19: -13M Q1 '20: -14.6M Q2 '20: -16M Q3 '20: -17.3M Q4 '20: -17M Q1 '21: -17.5M Q2 '21: -14.7M Q3 '21: -14.6M Q4 '21: -13.5M Q1 '22: -14.8M Q2 '22: -16.1M Q3 '22: -15.3M Q4 '22: -15.2M Q1 '23: -11.7M Q2 '23: -10.9M Q3 '23: -8.6M Q4 '23: -7.3M Q1 '24: -8.2M Q2 '24: -7.2M Q3 '24: -7.7M Q4 '24: -8.6M Q1 '25: -7.6M Q2 '25: -7.4M Q3 '25: -8.4M Q4 '25: -9.2M Q1 '26: -9.3M Q2 '26: -10.2M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

-18M -12M -6M 0 6M 12M 18M Q2 '14: -6.5M Q3 '14: -5.6M Q4 '14: -5.7M Q1 '15: -5.4M Q2 '15: -4.7M Q3 '15: -4.9M Q4 '15: -5.3M Q3 '22: -15.4M Q4 '22: -15.4M Q2 '14 Q4 '14 Q2 '15 Q4 '15 Q4 '22

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q1 '21: 103M Q2 '21: 115.9M Q3 '21: 116.3M Q1 '22: 2M Q2 '22: 1.9M Q3 '22: 1.9M Q1 '23: 2.2M Q2 '23: 2M Q3 '23: 2.4M Q1 '24: 3.5M Q2 '24: 151K Q3 '24: 217.6K Q1 '25: 607.2K Q2 '25: 731.8K Q3 '25: 1.6M Q1 '26: 4.3M Q2 '26: 4.4M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-60.00 -40.00 -20.00 0.00 20.00 40.00 60.00 Q2 '11: -1.42 Q1 '12: -1.32 Q2 '12: -1.42 Q3 '12: -1.21 Q4 '12: -0.95 Q1 '13: -0.76 Q2 '13: -0.32 Q3 '13: -0.55 Q4 '13: -0.57 Q1 '14: -0.56 Q2 '14: -0.53 Q3 '14: -0.22 Q4 '14: -0.16 Q1 '15: -0.15 Q1 '16: -0.33 Q2 '16: -0.17 Q3 '16: -0.16 Q4 '16: -1.57 Q1 '17: -1.92 Q2 '17: -2.16 Q3 '17: -2.54 Q4 '17: -1.37 Q1 '18: -1.39 Q2 '18: -1.52 Q1 '19: -0.93 Q2 '19: -0.65 Q3 '19: -0.38 Q4 '19: -0.37 Q1 '20: -0.37 Q2 '20: -0.51 Q3 '20: -0.51 Q4 '20: -0.47 Q1 '21: -0.41 Q2 '21: -0.20 Q3 '21: -0.16 Q4 '21: -0.14 Q1 '22: -2.38 Q2 '22: -4.20 Q3 '22: -6.15 Q4 '22: -7.03 Q1 '23: -6.15 Q2 '23: -5.81 Q3 '23: -4.67 Q4 '23: -9.25 Q1 '24: -8.54 Q2 '24: -22.30 Q3 '24: -32.77 Q4 '24: -47.88 Q1 '25: -50.83 Q2 '25: -38.66 Q3 '25: -29.30 Q4 '25: -4.56 Q1 '26: -1.42 Q2 '26: 1.11 Q4 '12 Q3 '14 Q1 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.